Literature DB >> 16961624

Barriers to the long-term use of low-molecular weight heparins for treatment of cancer-associated thrombosis.

A K Wittkowsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16961624     DOI： 10.1111/j.1538-7836.2006.02073.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  8 in total

1.  Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer.

Authors:  Thomas Delate; Daniel M Witt; Debra Ritzwoller; Jane C Weeks; Lawrence Kushi; Mark C Hornbrook; Erin J Aiello Bowles; Deborah Schrag
Journal:  Oncologist       Date:  2012-02-14

Review 2.  Anticoagulation in the management of venous thromboembolism in the cancer patient.

Authors:  Michael B Streiff
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

Review 3.  What is the Best Treatment for a Cancer Patient with Thrombosis?

Authors:  Miguel Barbosa
Journal:  Clin Med Insights Oncol       Date:  2014-05-01

Review 4.  Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants.

Authors:  C Ay; J Beyer-Westendorf; I Pabinger
Journal:  Ann Oncol       Date:  2019-06-01       Impact factor: 32.976

Review 5.  New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism.

Authors:  Kaidireyahan Wumaier; Wenqian Li; Jiuwei Cui
Journal:  Drug Des Devel Ther       Date:  2022-08-03       Impact factor: 4.319

Review 6.  Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options.

Authors:  Cihan Ay; Pieter Willem Kamphuisen; Giancarlo Agnelli
Journal:  ESMO Open       Date:  2017-06-08

Review 7.  Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence.

Authors:  I García-Escobar; E Brozos-Vázquez; D Gutierrez Abad; V Martínez-Marín; V Pachón; A J Muñoz Martín
Journal:  Clin Transl Oncol       Date:  2020-11-18       Impact factor: 3.405

8.  Current practice patterns and patient persistence with anticoagulant treatments for cancer-associated thrombosis.

Authors:  Alok A Khorana; Keith R McCrae; Dejan Milentijevic; Jonathan Fortier; Winnie W Nelson; François Laliberté; Concetta Crivera; Patrick Lefebvre; Daniel Yannicelli; Jeff Schein
Journal:  Res Pract Thromb Haemost       Date:  2017-05-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.